As National Hispanic Heritage Month concludes tomorrow, we'd like to take a moment to recognize the incredible contributions of our Hispanic and Latinx staff members, as well as our clinical research participants. Your dedication and commitment to clinical research continue to drive our mission forward, enriching our work and helping to advance critical healthcare solutions for all. Thank you for your hard work and for being an essential part of our journey toward improving health outcomes through inclusive clinical research. ?Gracias a todos! #HispanicHeritageMonth #ClinicalResearch #DiversityInResearch #AdvancingHealthcare #ResearchForAll #EvolutionResearchGroup #InclusiveResearch #TogetherWeThrive
Evolution Research Group
研究服务
New Providence,New Jersey 3,118 位关注者
Quality Clinical Research Today for a Healthier Tomorrow
关于我们
ERG is a leading U.S. based, privately held, independent clinical research site company, and provider of clinical development services with an expertise in early and late stage neuroscience drug development. With 21 wholly owned clinical sites and 5 affiliated sites, we conduct in-patient and out-patient phase I-IV clinical research studies. ERG has 340+ in-patient beds, a large and growing database of patients suffering from mental illness, neurological disorders, sleep disorders, addictions, Acute and Chronic Pain, diabetes and other illnesses as well as normal healthy volunteers who participate in trials for the advancement of medicine. With access to over 32 million patients/subjects and 5000 + completed trials, ERG continues to grow its capabilities and expand into indications where there are tremendous unmet medical needs in the United States and globally. The ERG portfolio of sites we own consists of Woodland International Research Group, Woodland Research Northwest, Midwest Clinical Research, Pacific Research Network, Clinical Pharmacology of Miami, Brain Matters Research, Neuropsychiatric Research Center, Richmond Behavioral Associates, Finger Lakes Clinical Research, Endeavor Clinical Trials, and HD Research, all supported by an industry leading centralized infrastructure located in New Jersey. ERG offers consulting services to pharmaceutical and CRO clients, including access to key opinion leaders in Schizophrenia, Pain, Alzheimer’s disease, Sleep Disorders, Depression, Hepatic/Renal Impairment, Podiatry and Clinical Pharmacology. This includes Rater Training Services, Centralized Data Services (ECG, PSG, EEG, qEEG, Actigraphy), Medical Writing Services, Study Feasibility and Site Recommendation ERG also offers general consulting in study design, protocol review and budget planning, vendor resources, Scientific Advisory Board Planning and Implementation, study feasibility and site recommendations.
- 网站
-
https://ergclinical.com
Evolution Research Group的外部链接
- 所属行业
- 研究服务
- 规模
- 501-1,000 人
- 总部
- New Providence,New Jersey
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Psychiatry: Schizophrenia (adult and adolescent), Bipolar Disorder (adult and pediatric/adolescent), Addiction (alcohol, cocaine), Opioid Use Disorder, Depressive Disorders (adult and pediatric/adolescent), ADHD (adult and pediatric/adolescent), Anxiety Disorders, Eating Disorders, PTSD, OCD、Neurology: Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, Essential Tremor,Sleep Disorders (insomnia, narcolepsy, RLS, apnea), Tourette’s Syndrome (adult and adolescent), Huntington’s Disease, Tardive Dyskinesia, Epilepsy、Pain: Post-Op Pain (breast augmentation, abdominoplasty, bunionectomy, total knee replacement, other orthopedic), PHN, Fibromyalgia, OA, DPN, Gout, CRPS, Headache (Migraine/Tension)、Healthy Volunteers: First-in-Human, First-to-File, PK/PD, SAD/MAD, DDI, FE, BA/BE, QTc/TQT、Renal Impairment and Hepatic Impairment、Geriatric and Healthy Geriatric、Smoking、Vaccine、Endocrinology: Type 1-2 Diabetes, Obesity、Liver Disease: Hepatitis B and C, NASH、Podiatry、Respiratory: Asthma (adult and pediatric/adolescent), COPD Cardiovascular Disorders: Hypertension, Hypercholesterolemia、Sexual Dysfunction Disorders、Asian Bridging、Respiratory: Asthma (adult and pediatric/adolescent), COPD Cardiovascular Disorders: Hypertension, Hypercholesterolemia和Gastrointestinal: GERD (adult and pediatric)
地点
Evolution Research Group员工
动态
-
Our team at Evolution Research Group is excited to be attending and hosting Booth 423 during ObesityWeek?, organized by The Obesity Society. This dedicated team is ready to connect with you and discuss our extensive capabilities in Obesity Research. Whether you’re a researcher, clinician, or industry professional, stop by to learn how we’re advancing innovative solutions in this critical field. See you at #OW2024! #ObesityResearch #ClinicalTrials #HealthcareInnovation #EvolutionResearchGroup #ObesityWeek #AdvancingScience #Collaboration
-
Our team from Evolution Research Group is excited to attend the CTAD Clinical Trials on Alzheimer's Disease in Madrid from October 29 to November 1st! Don’t miss the chance to connect with: Ana Fuquay, Executive Director, Therapeutic Area Lead Paayal Patel, Neurologist & Principal Investigator Holly George, Agitation Study?Initiative Lead Looking to schedule a meeting with us? Email us at [email protected] and let’s discuss how we can collaborate to advance ALZ research together. We look forward to seeing you in Madrid! #CTAD2024 #AlzheimersResearch #ClinicalResearch #ResearchExcellence #JoinTheConversation
-
Self-care isn’t just a luxury, it’s essential for maintaining mental well-being. Try these simple steps to keep your mind healthy. Remember, it’s okay to ask for help! Your mental health deserves attention and care. ?? #MentalHealthMatters #MentalHealthAwarenessWeek
-
The first full week of each October we celebrate Mental Health Awareness Week ending with World Mental Health Day! We are all impacted by mental health conditions, whether it be friends, family or our own personal journey. During this week, take a moment to focus on your own mental health and support others around you who may be struggling. Evolution Research Group is focused on building new science and therapies to help eliminate the symptoms of mental illness. We wish to thank each heroic research volunteer, dedicated research staff, fierce advocates and all those working towards mental health recovery.
-
Our team at Evolution Research Group is thrilled to be part of the upcoming CTAD Clinical Trials on Alzheimer's Disease conference from October 31st-November 1st in Madrid, Spain. We’re eager to explore the latest advancements in Alzheimer's research. If you're attending, let’s connect-whether to discuss groundbreaking innovations or just to say hi, we’d love to meet. Email us at [email protected] to schedule a meeting with our team. Together, we can continue making strides in fight against memory loss.
-
From the desk of Lori Wright: The future of Clinical Trials is bright, but it is not without its challenges. Recently, I had the privilege of joining industry leaders Paul Evans (CEO, Velocity Clinical Research, Inc.), Carlos Orantes (CEO, Alcanza Clinical Research), Aidrian Otte (Operating Partner, LongueVue Capital), and Jennifer Byrne (CEO, Javara) to discuss the evolving landscape of clinical trial site organizations. ? During this panel discussion, led by Jason Layton of Crosstree Capital, we delved into the complexities that PAOs, such as Evolution Research Group, face today—from optimizing patient recruitment to navigating ever-changing regulations. What stood out most to me was our shared commitment to innovation and patient-centricity, which are at the heart of transforming clinical trials. ? We are not just responding to the challenges but are driving the solutions that will shape the future of clinical research, including implementing cutting-edge technologies, streamlining site operations, enhancing patient access, and compressing study timelines, and redefining our role in the clinical development ecosystem.??I am excited to continue this journey alongside such forward-thinking leaders who are as passionate as I am about advancing research. ? For those who missed it, you can watch the full discussion and gain insights from those on the front lines of this transformation by clicking below. ? ???https://hubs.li/Q02R8VwC0
-
Industry leaders are coming together to explore the future of Patient Access Organizations (aka Clinical Trial Site Organizations). Paul Evans (CEO, Velocity Clinical Research, Inc.), Lori Wright (CEO, Evolution Research Group), Carlos Orantes (CEO, Alcanza Clinical Research), Aidrian Otte (Operating Partner, LongueVue Capital) and Jennifer Byrne (CEO, Javara) share their insights on the challenges and opportunities facing clinical trials today. From patient recruitment to navigating complex regulations, these experts discuss how PAOs are driving innovation and transforming the clinical research landscape. Watch the full panel discussion for a deeper dive into the future of clinical trials with perspectives from those shaping the industry. https://hubs.li/Q02R8VwC0 #InvestmentBanking #MergersandAcquisitions #ClinicalResearch #PatientAccessOrganizations #HealthcareInnovation
-
September is Suicide Prevention Month—a crucial time to recognize the impact of mental health challenges and the importance of compassionate support. At Evolution Research Group, we are dedicated to advancing research in mental health to create better futures for those affected. Together, we stand committed to raising awareness, fostering understanding, and driving the innovation needed to save lives and support those in need.